Certificate of Analysis
GLP-3 (RT) — lot RET1025
Values below are transcribed from the signed certificate for this lot, issued by an ISO/IEC 17025 accredited laboratory and tested Dec 19, 2025. They describe the material’s identity and purity only.
99.72%
Purity by HPLC
| Compound identity | Retatrutide |
|---|---|
| Variant | GLP-3 (RT) · 10 mg |
| Lot number | RET1025 |
| Labeled amount | 10 mg |
| Assayed net peptide | 10.55 mg |
| Purity (HPLC) | 99.72% |
| Date tested | Dec 19, 2025 |
| Sterility (USP <71>) | No growth detected |
| Bacterial endotoxin (LAL) | < 0.05 EU/mg |
| Heavy metals (ICP-MS) | Screened — Cr, As, Cd, Pb, Hg |
| Issuing laboratory | Vanguard Laboratory |
| Accreditation | ISO/IEC 17025 (A2LA cert #6377.01.01) |
Sold as GLP-3 (RT). Compound identity on the certificate: retatrutide.
Research use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.